A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro

Biochemical and Biophysical Research Communications

Volumn 270, Issue 3, 2000, Pages 1124-1127

  Carron, J A ^a   Wagstaff, S C ^a   Gallagher, J A ^a   Bowler, W B ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Bone resorption; CD36; Osteoclast; Thrombospondin

Indexed keywords

BINDING PROTEIN; CD36 ANTIGEN; THROMBOSPONDIN 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE ATROPHY; BONE CELL; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; FOWL; IMMUNOBLOTTING; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOMA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE;

ANIMALIA; AVES; GALLIFORMES;

EID: 0034696847     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2574     Document Type: Article

References (31)

1. Lawler J. The structural and functional properties of thrombospondin. Blood. 67:1986;1197-1209.
2. Frazier W. A. Thrombospondin - A molecular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol. 105:1987;625-632.
3. Majack R. A., Goodman L. V., Dixit V. M. Cell-surface thrombospondin is functionally essential for vascular smooth-muscle cell proliferation. J. Cell Biol. 106:1988;415-422.
4. Murphy-Ullricht J. E., Hook M. Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 109:1989;1309-1319.
5. Roberts D. D., Sherwood J. A., Ginsberg V. Platelet thrombospondin mediates attatchment and spreading of human melanoma cells. J. Cell Biol. 104:1987;131-139.
6. Taraboletti G., Roberts D., Liotta L. A., Giavazzi R. Platelet thrombospondin modulates endothelial-cell adhesion, motility, and growth - A potential angiogenesis regulatory factor. J. Cell Biol. 111:1990;765-772.
7. Good D. J., Polverini P. J., Rastinejad F., Lebeau M. M., Lemons R. S., Frazier W. A., Bouck N. P. A tumour suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA. 87:1990;6624-6628.
8. Hogg P. J., Stenflo J., Mosher D. F. Thrombospondin as a slow tight-binding inhibitor of plasmin. Biochemistry. 31:1992;265-269.
9. Hogg P. J., Owensby D. A., Chesterman C. N. Thrombospondin-1 is a tight-binding competitive inhibitor of neutrophil cathepsin-G-determination of the kinetic mechanism of inhibition and localization of cathepsin-G binding to the thrombospondin-1 type-3 repeats. J. Biol. Chem. 268:1993;21811-21818.
10. Savill J., Hogg N., Ren Y., Haslett C. Thrombospondin co-operates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1992;1513-1522.
11. Prater C. A., Plotkin J., Jaye D., Frazier W. A. The properdin-like type-1 repeats of human thrombospondin contain a cell attachment site. J. Cell Biol. 112:1991;1031-1040.
12. Sun X., Kaesberg P. R., Choay J., Harenberg J., Ershler W. B., Mosher D. F. Effects of sized heparin oligosaccaride on the interactions of Chinese-hamster ovary cell with thrombospondin. Semin. Thromb. Hemostasis. 18:1992;234-251.
13. Lawler J., Hynes R. O. An intergrin receptor on normal and thrombasthenic platelets that bind thrombospondin. Blood. 74:1989;2022-2027.
14. Asch A. S., Silbiger S., Heimer E., Nachman R. L. CD36-transfected Jurkat cells bind thrombospondin via a malaria-homologous domain. Clin. Res. 39:1991;A338.
15. Gao A. G., Lindberg F. P., Finn M. B., Blystone S. D., Brown E. J., Frazier W. A. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:1996;21-24.
16. Acsh A. S., Silbiger S., Heimer E., Nachman R. L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 182:1992;1208-1217.
17. Carron J. A., Walsh C. A., Fraser W. D., Gallagher J. A. Thrombospondin promotes resorption by osteoclasts in vitro. Biochem. Biophys. Res. Commun. 213:1995;1017-1025.
18. Walsh C. A., Dawson W. E., Birch M. A., Gallagher J. A. The effects of extracellular pH on bone-resorption by avian osteoclasts in vitro. J. Bone Miner. Res. 5:1990;1243-1247.
19. Walsh C. A., Beresford J. N., Birch M. A., Boothroyd B., Gallagher J. A. Application of reflected light-microscopy to identify and quantitate resorption by isolated osteoclasts. J. Bone Miner. Res. 6:1991;661-671.
20. Horton M. A., Taylor M. L., Arnett T. R., Helfrich M. H. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195:1991;368-375.
21. Tandon N. N., Diazricart M., Lotfalian B., Ockenhouse C. F., Jamieson G. A. Different domains of CD36 mediate collagen adhesion and malarial cytoadherence. Thromb. Haemostasis. 73:1995;1355.
22. Nicholson A. C., Frieda S., Pearce A., Silverstein R. L. Oxidised LDL binds to CD36 on human monocyte-derived macrophages and transfected cell-lines - Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arteriosclerosis Thromb. Vasc. Biol. 15:1995;269-275.
23. Daviet L., McGregor J. L. Functional roles of membrane glycoprotein CD36. Platelets. 7:1996;117-124.
24. Tooney P. A., Sakari T., Sakai K., Aeschlimann D., Mosher D. F. Restricted localisation of thrombospondin-2 protein during mouse embryogenesis: A comparison to thrombospondin-1. Matrix Biol. 17:1998;131-143.
25. Kryiakides T. R., Zhu Y. H., Smith L. T., Bain S. D., Yang Z. T., Lin M. T., Danielson K. G., Iozzo R. V., LaMarca M., Mcinney C. E., Ginns E. I., Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol. 140:1998;419-430.
26. Lawler J., Sunday M., Thibert V., Duquette M., George E. L., Rayburn H., Hynes R. O. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101:1998;982-992.
27. Yamamoto N., Akamatsu N., Sakuraba H., Yamazaki H., Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type-I) or the presence (type-II) of glycoprotein-IV on monocytes. Blood. 83:1994;392-397.
28. Huang M. M., Bolen J. B., Barnwell J. W., Shattil S. J., Brugge J. S. Membrane glycoprotein-IV (CD36) is physically associated with the fyn, lyn and yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. USA. 88:1991;7844-7848.
29. Bull H. A., Brickell P. M., Dowd P. M. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 351:1994;41-44.
30. Boyce B. F., Yoneda T., Lowe C., Soriano P., Mundy G. R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1992;1622-1627.
31. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:1991;693-702.